Insider Transactions in Q1 2023 at Cerus Corp (CERS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2023
|
Carol Moore SVP Reg. & Quality |
SELL
Open market or private sale
|
Direct |
13,078
-1.57%
|
$26,156
$2.8 P/Share
|
|
Mar 13
2023
|
Vivek K Jayaraman Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,356
-1.92%
|
$50,712
$2.8 P/Share
|
|
Mar 13
2023
|
Chrystal Menard Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,468
-2.2%
|
$30,936
$2.8 P/Share
|
|
Mar 13
2023
|
William Mariner Greenman President and CEO |
SELL
Open market or private sale
|
Direct |
60,480
-1.14%
|
$120,960
$2.8 P/Share
|
|
Mar 13
2023
|
Kevin Dennis Green Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,163
-1.97%
|
$34,326
$2.8 P/Share
|
|
Mar 13
2023
|
Richard J Benjamin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,353
-2.36%
|
$50,706
$2.79 P/Share
|
|
Mar 13
2023
|
Laurence M Corash Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,342
-0.34%
|
$30,684
$2.8 P/Share
|
|
Mar 12
2023
|
Carol Moore SVP Reg. & Quality |
BUY
Exercise of conversion of derivative security
|
Direct |
35,127
+4.01%
|
-
|
|
Mar 12
2023
|
Vivek K Jayaraman Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,200
+4.95%
|
-
|
|
Mar 12
2023
|
Chrystal Menard Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,127
+5.4%
|
-
|
|
Mar 12
2023
|
William Mariner Greenman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
172,192
+3.12%
|
-
|
|
Mar 12
2023
|
Kevin Dennis Green Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,127
+4.91%
|
-
|
|
Mar 12
2023
|
Richard J Benjamin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,127
+5.28%
|
-
|
|
Mar 12
2023
|
Laurence M Corash Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,127
+0.88%
|
-
|
|
Mar 01
2023
|
Chrystal Menard Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+33.0%
|
-
|
|
Mar 01
2023
|
Carol Moore SVP Reg. & Quality |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+21.83%
|
-
|
|
Mar 01
2023
|
Laurence M Corash Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+4.69%
|
-
|
|
Mar 01
2023
|
Kevin Dennis Green Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185,000
+31.2%
|
-
|
|
Mar 01
2023
|
William Mariner Greenman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
575,000
+18.42%
|
-
|
|
Mar 01
2023
|
Vivek K Jayaraman Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
240,000
+28.1%
|
-
|
|
Mar 01
2023
|
Richard J Benjamin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+32.48%
|
-
|